MGTX
Price
$12.79
Change
-$0.06 (-0.47%)
Updated
Sep 11 closing price
Capitalization
1.23B
67 days until earnings call
Intraday BUY SELL Signals
SVRA
Price
$5.30
Change
-$0.02 (-0.38%)
Updated
Sep 11 closing price
Capitalization
1.09B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MGTX vs SVRA

MGTX vs SVRA Comparison Chart in %
View a ticker or compare two or three
VS
MGTX vs. SVRA commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a StrongBuy and SVRA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($1.23B) has a higher market cap than SVRA($1.09B). MGTX YTD gains are higher at: 60.881 vs. SVRA (-12.106). MGTX has higher annual earnings (EBITDA): 106M vs. SVRA (-142.66M). SVRA has more cash in the bank: 173M vs. MGTX (143M). SVRA has less debt than MGTX: SVRA (30.4M) vs MGTX (112M). MGTX has higher revenues than SVRA: MGTX (398M) vs SVRA (0).
MGTXSVRAMGTX / SVRA
Capitalization1.23B1.09B113%
EBITDA106M-142.66M-74%
Gain YTD60.881-12.106-503%
P/E Ratio14.71N/A-
Revenue398M0-
Total Cash143M173M83%
Total Debt112M30.4M368%
FUNDAMENTALS RATINGS
MGTX vs SVRA: Fundamental Ratings
MGTX
SVRA
OUTLOOK RATING
1..100
5973
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
10044
SMR RATING
1..100
1799
PRICE GROWTH RATING
1..100
3749
P/E GROWTH RATING
1..100
37100
SEASONALITY SCORE
1..100
n/a28

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SVRA's Valuation (61) in the Biotechnology industry is in the same range as MGTX (72). This means that SVRA’s stock grew similarly to MGTX’s over the last 12 months.

SVRA's Profit vs Risk Rating (44) in the Biotechnology industry is somewhat better than the same rating for MGTX (100). This means that SVRA’s stock grew somewhat faster than MGTX’s over the last 12 months.

MGTX's SMR Rating (17) in the Biotechnology industry is significantly better than the same rating for SVRA (99). This means that MGTX’s stock grew significantly faster than SVRA’s over the last 12 months.

MGTX's Price Growth Rating (37) in the Biotechnology industry is in the same range as SVRA (49). This means that MGTX’s stock grew similarly to SVRA’s over the last 12 months.

MGTX's P/E Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for SVRA (100). This means that MGTX’s stock grew somewhat faster than SVRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXSVRA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 18 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (MGTX: $12.79 vs. SVRA: $5.30)
Brand notoriety: MGTX and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 75% vs. SVRA: 62%
Market capitalization -- MGTX: $1.23B vs. SVRA: $1.09B
MGTX [@Biotechnology] is valued at $1.23B. SVRA’s [@Biotechnology] market capitalization is $1.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 1 FA rating(s) are green while SVRA’s FA Score has 0 green FA rating(s).

  • MGTX’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 4 TA indicator(s) are bullish while SVRA’s TA Score has 2 bullish TA indicator(s).

  • MGTX’s TA Score: 4 bullish, 5 bearish.
  • SVRA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than SVRA.

Price Growth

MGTX (@Biotechnology) experienced а -7.92% price change this week, while SVRA (@Biotechnology) price change was -1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

MGTX is expected to report earnings on Nov 18, 2026.

SVRA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MGTX
Daily Signal:
Gain/Loss:
SVRA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBAFX40.470.10
+0.25%
American Funds American Balanced 529-F-2
HOORX31.83N/A
N/A
Hartford Schroders US Small Cap Opps R3
LMTIX30.61N/A
N/A
Franklin U.S. Large Cap Equity I
PREFX92.16N/A
N/A
T. Rowe Price Tax-Efficient Equity
FTXAX63.40N/A
N/A
FullerThaler Behavioral Sm-Cp Gr A

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-0.47%
EDIT - MGTX
54%
Loosely correlated
+1.89%
SANA - MGTX
51%
Loosely correlated
+1.29%
VIR - MGTX
48%
Loosely correlated
+0.38%
DNLI - MGTX
46%
Loosely correlated
-1.45%
CRBU - MGTX
46%
Loosely correlated
-7.30%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with FDMT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-0.38%
FDMT - SVRA
45%
Loosely correlated
-2.37%
MGTX - SVRA
43%
Loosely correlated
-0.47%
NUVB - SVRA
42%
Loosely correlated
-3.34%
NRIX - SVRA
41%
Loosely correlated
-2.75%
PHVS - SVRA
41%
Loosely correlated
+1.36%
More